Doctor profile · Federal record

Dr. David McLain, M.D.

Rheumatology Physician (CMS: Rheumatology) · Birmingham, AL

  • NPI 1689614737
  • Accepts Medicare
  • MIPS 94.1 / 100 · 2023
  • 52 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2229 Cahaba Valley Dr
Birmingham, AL 352422602
(205) 991-8996
fax (205) 991-8997

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
October 21, 2020
Year of graduation
1974 — 52 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Alabama #9639

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1689614737. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
8,469
Distinct HCPCS
10
Medicare allowed
$277,976
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 5,580 65 $23
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,157 168 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 695 403 $116
20610 Aspiration and/or injection of fluid from large joint 299 154 $64
99213 Established patient office or other outpatient visit, 20-29 minutes 290 201 $84
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 102 71 $65
96372 Injection of drug or substance under skin or into muscle 68 20 $13
J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose 58 22 $74
20600 Aspiration and/or injection of fluid from small joint 56 37 $48
80305 Testing for presence of drug, read by direct observation 54 49 $12

In context: peer comparison

Among 7 peers in Birmingham Rheumatology Physician, average services per provider: 5,030. This provider delivers 1.7× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$186,852
Transactions
201
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 61 $182,650.89
Amgen INC. 28 $591.02
GlaxoSmithKline, LLC. 15 $557.34
Janssen Biotech, INC. 11 $368.82
Ucb, INC. 16 $365.32
Pfizer INC. 19 $344.85
Kyowa Kirin, INC. 7 $213.64
Ani Pharmaceuticals, INC. 7 $206.92
AstraZeneca Pharmaceuticals Lp 11 $197.94
Mallinckrodt Hospital Products INC. 6 $149.93
Novartis Pharmaceuticals Corporation 7 $148.97
Genzyme Corporation 1 $147.37
Boehringer Ingelheim Pharmaceuticals, INC. 5 $135.74
Janssen Scientific Affairs, LLC 1 $115.92
Scilex Pharmaceuticals INC. 6 $111.63

By nature of payment

Grant
$181,425
Food and Beverage
$5,407
Education
$19

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
12,174
Patients
2,132
Total drug cost
$393,009
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 2,364 475 $152,065
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 2,073 253 $51,488
Tizanidine Hcl Generic 979 200 $14,597
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 896 121 $33,942
Gabapentin Generic 804 143 $8,771
Tramadol Hcl Generic 667 125 $5,259
Leflunomide Generic 612 116 $65,373
Prednisone Generic 568 109 $5,136
Methotrexate (Methotrexate Sodium) Brand 500 99 $18,474
Alprazolam Generic 484 71 $2,543

Frequently asked questions

Auto-generated from federal data
What is Dr. David McLain's medical specialty?
Dr. David McLain practices Rheumatology Physician in Birmingham, AL.
Where does Dr. David McLain practice?
Dr. David McLain practices at 2229 Cahaba Valley Dr, Birmingham, AL 352422602. Office phone: 2059918996.
What is Dr. David McLain's NPI?
Dr. David McLain's National Provider Identifier (NPI) is 1689614737, issued by NPPES.
Does Dr. David McLain accept Medicare assignment?
Yes. Dr. David McLain accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David McLain commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.